Biotechnology firm Biocon on Friday said its board has approved to raise up to Rs 600 crore in one or more tranches on a private placement basis. The company's board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis, the company said in a regulatory filing.
It, however, did not disclose reasons for raising the capital.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT
RECOMMENDED FOR YOU
Cipla, Biocon, Lupin, Other Pharma Stocks Under Pressure Post Trump's 100% Tariff
Sep 26, 2025
NDTV Profit Reborn: For Your Profit
Sep 09, 2025
ACME Solar Holdings Seeks Shareholders' Nod To Raise Up To Rs 3,000 Crore Via Securities
Sep 02, 2025
6 In 10 Train Passengers In Favour Of New Luggage Norms, Sceptical On Implementation: LocalCircles
Aug 22, 2025
POPULAR
1
Tax Loophole? 'Buy Farmhouse In ...': CA Explains How Rich Indians Avoid Taxes
2
SpiceJet Adds Daily Non-Stop Flights To Phuket Starting Oct 31
3
Silver Rate Today: Price Surges To All-Time-High; Check Rates In Delhi, Mumbai, Chennai, Other Cities
4
Sterlite Copper Fulfils Anil Agarwal's Plea To Help Out Chennai's 80-Year-Old Sweet Seller; 'This Diwali...'
5
